Drug Research

The adoption of lifecycle management to ensure the quality of pharmaceutical products has been discussed extensively over recent years. The modern concept of method lifecycle management (MLCM) provides a framework for defining the criteria and development of analytical methods, aiming...

Lonza has further expanded its hepatocytes portfolio characterization with the addition of Verified for Spheroids Human Hepatocytes, which are pre-screened for their ability to promote rapid spheroid formation in cell culture. Researchers working in toxicology, disease...

Sapreme Technologies, a privately-held biotech company developing a technology platform to enable the cytosolic delivery of macromolecule therapeutics, has been awarded a 6.8 M€ grant together with a multidisciplinary consortium including 11 other academic and industrial parties. ...

Jubilant Biosys announced a new integrated drug discovery collaboration with Sanofi in the CNS therapeutic area. The first collaboration with Sanofi started in 2016, to discover and develop small molecule inhibitors for multiple targets in the...

Samsung Bioepis Co., Ltd. announced its expansion in mainland China through a licensing agreement with C-Bridge Capital. The agreement covers multiple biosimilar candidates from Samsung Bioepis, including third-wave biosimilar candidates SB11 and SB12, which reference LUCENTIS®...

Pathios Therapeutics, an innovative biotech company focused on the development of first-in-class therapies for autoimmune diseases and immuno-oncology and Sygnature Discovery have announced a strategic partnership to accelerate Pathios’ drug discovery and development programmes. As part...

Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for rare and orphan diseases along with oncology, infectious diseases, and vaccines, is now enrolling patients in the U.S. and Europe into a pivotal Phase III study within the...